<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="teaser">
 <p>A phase II study of preoperative docetaxel/cisplatin/S-1 therapy for locally advanced gastric cancer was feasible, but the pathological response rate did not achieve the expected value.</p>
</abstract>
